Business

Moderna, a well-known biotech company, has recently announced that the approval of its vaccine for respiratory syncytial virus (RSV) has been delayed by the Food and Drug Administration (FDA) until the end of May. This delay has been attributed to “administrative constraints” at the agency, causing uncertainty among investors and stakeholders. The FDA’s decision to
0 Comments
In the ever-evolving landscape of the restaurant industry, casual dining chains like Applebee’s and IHOP are facing fierce competition from fast-food establishments and the growing trend of eating at home. With consumers becoming increasingly conscious of their spending, these traditional sit-down restaurants are having to find new ways to attract and retain customers. Dine Brands,
0 Comments
Oddity Tech, the Israeli cosmetics platform utilizing artificial intelligence to develop products, recently revealed its first-quarter results, which exceeded expectations. The company reported earnings per share of 61 cents adjusted, surpassing the anticipated 49 cents. Additionally, revenue reached $211.63 million, outperforming the $205 million that Wall Street analysts had projected. For the three-month period ending
0 Comments
Howard Schultz, former Starbucks CEO, recently commented on the struggling coffee chain’s latest quarterly report, stating that he believes the company has the potential to bounce back if it focuses on enhancing its U.S. stores. Despite no longer holding an official position at Starbucks, Schultz emphasized the importance of improving the mobile order and pay
0 Comments
Wayfair, the online furniture retailer, reported a decrease in sales during its first quarter. However, the company managed to reduce its losses after implementing a workforce reduction of 13% at the beginning of the year. Despite the decline in sales, Wayfair exceeded Wall Street’s expectations both in terms of revenue and loss per share. Active
0 Comments
Johnson & Johnson recently announced plans to pay $6.5 billion over 25 years to settle the majority of the lawsuits in the U.S. alleging that its talc-based products caused ovarian cancer. This move comes after years of financial and public relations challenges for the company, which has long maintained that its talc products are safe
0 Comments